IL6 and neoplasm: TLR4 activation in prostate cancer cells promotes tumor progression: LPS stimulation in DU145 cells triggers NF-κB–dependent production of IL-6 and IL-1β, while in PC3 cells it enhances VEGF and TGF-β1 expression (42, 43).